Literature DB >> 27598217

NMR Chemical Shift Ranges of Urine Metabolites in Various Organic Solvents.

Benjamin Görling1,2, Stefan Bräse3,4, Burkhard Luy5,6.   

Abstract

Signal stability is essential for reliable multivariate data analysis. Urine samples show strong variance in signal positions due to inter patient differences. Here we study the exchange of the solvent of a defined urine matrix and how it affects signal and integral stability of the urinary metabolites by NMR spectroscopy. The exchange solvents were methanol, acetonitrile, dimethyl sulfoxide, chloroform, acetone, dichloromethane, and dimethyl formamide. Some of these solvents showed promising results with a single batch of urine. To evaluate further differences between urine samples, various acid, base, and salt solutions were added in a defined way mimicking to some extent inter human differences. Corresponding chemical shift changes were monitored.

Entities:  

Keywords:  DMSO; NMR spectroscopy; methanol; solvents; urine

Year:  2016        PMID: 27598217      PMCID: PMC5041126          DOI: 10.3390/metabo6030027

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


1. Introduction

Metabolomics is a powerful tool to analyze differences and perturbations in the metabolic profiles of biological samples like blood plasma/serum, urine, and extracts of tissue, feces, and cells. Especially, nuclear magnetic resonance (NMR) spectroscopy has proven to be an easy and versatile tool to analyze these biological samples [1,2,3]. Urine itself is a highly variable bioliquid with a plethora of endogenous metabolites [4] and very large variations in their signal positions even after the addition of a considerable amount of buffer [5,6]. The variations are mainly subjected to inter-human differences in nutrition and physical condition [6]. Nevertheless, the urine profile of a single person can show strong variations during the day as well. These differences result in altered metabolite concentrations, pH, ionic strength, and amount of divalent ions [7,8,9,10,11]. Values of pH can vary in a range from 4.6 to 8.0 [12] and ionic strength by a factor of 10 [13]. Additionally, in special cases degradation of organic metabolites may occur due to bacterial contamination [14]. Variability in signal position will complicate multivariate data analysis. To reduce the variability in signal position, several approaches have been developed including dilution, adjusting the mixing ratio of urine and buffer and treatment with EDTA (=Ethylenediaminetetraacetic acid) or KF to reduce the effect of the divalent ions Ca2+ and Mg2+ [9,11,15]. For tissue samples or samples that are extracted prior to analysis, much narrower ranges have been reported [16,17,18,19]. The search for an ideal urine matrix is therefore steadily continuing. As various organic solvents like methanol and acetonitrile have shown very narrow distributions of metabolite chemical shift ranges in other bioliquids and liquid foods (Bruker, private communication), the idea of solvent exchange to test this hypothesis was born. The aim of this study was therefore to test if urine in different solvents shows less variability in terms of signal positions and increased sample stability in terms of data interpretation.

2. Results and Discussion

To test the reproducibility and the stability of signal positions, urine samples were lyophilized for two days and the residue was dissolved in the desired solvent. The used solvents were D2O, methanol-d4 (MeOD), acetonitrile-d3 (MeCN), dimethyl sulfoxide-d6 (DMSO), CDCl3, acetone-d6, dichloromethane-d2 (DCM), and N,N-dimethyl formamide-d7 (DMF). Five individual replicates of a single batch of human urine were prepared for each solvent. Complete dissolution could only be achieved with water as solvent. In the polar solvents MeOD, DMSO, and DMF most of the substances could be dissolved and there was only a minor residue in the centrifuge tube. In the remaining solvents MeCN, CDCl3, acetone, and DCM nearly no difference to the freshly lyophilized residue could be observed, indicating insufficient solubility of the urine matrix in these solvents (Figure 1).
Figure 1

Residue of lyophilized urine samples before (Lyo) and after dissolution in various solvents. With D2O as the solvent, no residual remainders are visible, with MeOD, DMSO, and DMF a minor debris is visible and with MeCN, CDCl3, acetone, and DCM nearly no difference to the undissolved sample is visible, indicating substantially incomplete dissolution.

Main components in the residue of the polar solvents MeOD, DMSO, and DMF are most likely salts that are only completely soluble in water. Most of the relevant metabolites can be considered to be dissolved and only slight differences in the concentrations should be visible. It should be noted that even substances with low solubility in organic solvents, like for example alanine [20], are still readily dissolved as the concentration present in urine is sufficiently low [21]. As a test, integral values of five exemplarily chosen metabolites were calculated for each solvent. The evaluated metabolites were hippurate, creatinine, lactate, histidine, and alanine. The only metabolite present in all solvents was hippurate, while creatinine and lactate were found in all solvents but chloroform and dichloromethane. Histidine and alanine were solely found in water, methanol, DMSO, and DMF. The relative standard deviation of the integral values shows very good reproducibility for water with values below 2% for all metabolites. Methanol and DMSO show a good reproducibility with relative standard deviations below 7% for methanol and around 10% for DMSO for all metabolites. The last solvent which showed good solubility of the urine matrix, DMF, has a good reproducibility for most of the examined metabolites (relative standard deviation below 10%) but very strong variations in the histidine signal (75%). This is caused by an intensive signal next to the histidine signal that overlaps quite strongly in some samples. Acetonitrile and acetone with at least three of the five evaluated metabolites present, show both strong variations with relative standard deviations of up to 44% for MeCN and 27% for acetone. Although the variations in chloroform and dichloromethane are relatively small, only one of the metabolite was found, eliminating them as suitable solvents in metabolomics-type studies. Results are summarized in Table 1 and Figure 2.
Table 1

Relative standard deviation of selected integral values.

SolventHippurateCreatinineLactateHistidineAlanine
D2O0.86%1.15%1.20%1.70%1.35%
MeOD2.76%3.29%0.60%7.01%1.99%
DMSO6.92%11.16%12.01%7.30%6.64%
DMF1.10%1.60%7.03%74.12%9.37%
MeCN31.83%27.97%43.27%--
Acetone26.84%4.66%10.74%--
CDCl315.65%----
DCM4.83%----
Figure 2

Mean integrals with standard deviations for the selected metabolites.

Comparing the intensity of the integrals to the values in water (Table 2), it is striking that some integrals are higher in MeOD, DMSO, and DMF as compared to the original urine sample. It can be assumed that all metabolites are completely dissolved in water after freeze drying and we cannot think of any reason why this should not be the case here. Slight differences in the integral values can occur due to strongly varying baseline levels for all solvents and an imperfect baseline subtraction prior to integration. Given the strong differences for example in methanol (1.3 for hippurate and creatinine and 1.6 for histidine), there must be an effect of the solvents. The most probable explanation is a reduction of the T1 time of the metabolites, resulting in a better polarization recovery into the equilibrium state and thereby more intense signals when using the identical duration of the experiment. Indeed, measurement of T1 times on a separate urine sample lyophylized and redissolved in the various solvents indicates relaxation times larger than 2 s for almost all metabolites investigated in D2O, while they are shorter in MeOD, DMSO, and DMF (Figure S1). Considering the applied recovery delay of 4 s and acquisition time of approximately 2.6 s as commonly applied periods in urine NMR studies, insufficient relaxation especially of histidine, hippurate, and creatinine are expected.
Table 2

Relative integrals to water as solvent.

SolventHippurateCreatinineLactateHistidineAlanine
MeOD1.301.300.961.641.01
DMSO1.181.100.461.390.65
DMF1.341.590.380.200.59
MeCN0.220.150.10--
Acetone0.320.110.09--
CDCl30.13----
DCM0.08----
The variation in signal position for the five replicates for each solvent is shown in Figure 3. The signal positions of the metabolites lactate and hippurate seem to be very robust, because there are only minor shifts in the signal position visible. Still, shifts of more than 0.1 ppm can be observed between the different solvents. The same trend can be seen for alanine and creatinine but with stronger variations in the signal position within individual solvents. As expected, the biggest variations can be observed in the histidine signal: between solvents, its position shifts over a range of more than 0.7 ppm, while within one solvent, the variation can be up to 0.1 ppm (DMF). While differences in the chemical shift values between the solvents are expected and known [22], variation within one solvent should be considered to be low. Interestingly, in all cases, the smallest variations of signal positions were found in water.
Figure 3

Signal positions of selected metabolites. The black bar represents the center of the signal and its shift over all replicates. The grey box represents the area of the whole signal over all replicates. (A) histidine; (B) hippurate; (C) creatinine; (D) alanine; (E) lactate.

Given the bad solubility of the urine matrix in chloroform and dichloromethane, the big relative standard deviation in acetone and acetonitrile and the large variations in signal positions in DMF, only methanol and DMSO seem to be suitable as solvents for the urine matrix—besides water, of course. The replicates used were only technical replicates of a single batch of urine. To simulate differences in pH and salt concentration between individuals to some extent, new urine samples of the same batch were prepared and various acid, base, and salt solutions were added in a controlled way. A first effect concerning all added solutions tested is directly visible in the positions of the signals (Figure 4). All signals are shifted, but the strength and direction of the shift depends on the solvent and the added acid/base/salt. In water, the addition of HCl shifts the selected signals in the opposite direction compared to NaOH and the basic salts NaHCO3 and Na2CO3. Furthermore, the direction of the shifts for one solution is not always the same for the five selected metabolites. While the addition of HCl to the aqueous samples shifts the signals of histidine and creatinine to higher ppm values, it shifts the signals of lactate, alanine, and hippurate to lower ppm values. For hippurate and lactate in MeOD and DMSO matrices instead, the signal positions are always shifted to higher ppm values for all added solutions. Again, the effect is strongest for the very pH-sensitive metabolite histidine which can be observed within an area of 0.54 ppm for water, 0.76 ppm for MeOD, and 0.38 ppm for DMSO (Figure 4).
Figure 4

Effect of various acid, base, and salt solutions on the signal positions of selected metabolites in urine samples. Shifts are shown relative to the samples without any acid/base/salt solution added. (A) histidine; (B) hippurate; (C): creatinine; (D) alanine; (E) lactate.

The reported shifts for all solvents are relative to TSP. Since the standard for organic solvents is usually TMS, reference experiments were performed to get also the shift of TMS relative to TSP. For the used solvents, shifts in positive and negative directions up to 0.02 ppm could be observed (Figure 5).
Figure 5

Chemical shift of TMS relative to TSP for all organic solvents.

The solvents’ ability to dissolve the urine matrix correlates directly with the empiric polarity determined by solvent shifts in absorption spectra (Table 3) [23]. The only exception that does not fit into this row is acetonitrile. Apparently, next to polarity, the ability to form hydrogen bonds is important as well.
Table 3

Relative polarity of the used solvents [23].

H2OMeODMeCNDMSODMFAcetoneDCMCHCl3
ETN1.0000.7620.4600.4440.3860.3550.3090.259
The deviations in signal positions are minimal for water both when exchanging the solvent and when adding an acid, base, or salt solution. Only when adding the acid/base/salt solutions to DMSO, the shift area is smaller for creatinine and histidine. As addition of these solutions also can be seen as one way to simulate chemical shift changes among different urines, it can be concluded that the salt dependence of unbuffered (!) water is always better compared to other solvents. Using buffer, the situation for water should even improve significantly. In essence, the current study presents another argument for investigating urine in its original aqueous matrix. While it comes with the least processing of samples, it has the least solubility problems, and has a multitude of chemical shift data available in corresponding databases, the minimum variation in chemical shift positions as compared to other solvents are all clear indications for H2O/D2O as the preferred NMR solvent of urine samples.

3. Materials and Methods

Spot urine of a single healthy male human was collected in the morning and directly used for analysis. To test the reproducibility, five samples for each solvent were prepared individually. In a 15 mL centrifuge tube, 1000 μL urine and 111 μL TSP (3-(trimethylsilyl)-2,2,3,3-tetradeuteropropionic acid) solution (0.1 wt % in D2O) were mixed, frozen in liquid nitrogen, and lyophilized for two days. The residue was mixed with 1000 μL of a deuterated solvent (D2O, methanol-d4 (MeOD), acetonitrile-d3 (MeCN), dimethyl sulfoxide-d6 (DMSO), CDCl3, acetone-d6, dichloromethane-d2 (DCM), dimethyl formamide-d7 (DMF)) and shaken for 10 min (neolab Intelli Mixer, program: u1, speed: 85 rpm). The mixture was transferred into a 2 mL microcentrifuge tube and centrifuged for 10 min at 14,000 rpm. 600 μL of the supernatant were transferred into a 5 mm standard NMR tube. To test the stability of signal positions, also samples with added acid, base, or salts were compared, for which three samples for each acid/base/salt were prepared individually. In a 15 mL centrifuge tube, 810 μL urine and 90 μL TSP solution (0.1 wt % in D2O) were mixed, frozen in liquid nitrogen and lyophilized for two days. The residue was mixed with 810 μL of D2O, methanol-d4 or dimethyl sulfoxide-d6 and 81 μL of an acid/base/salt solution (0.1 M HCl (aq.), 0.1 M NaOH (aq.), 0.1 M NaHCO3 (aq.), 0.1 M Na2CO3 (aq.)) and shaken and centrifuged as described above. 600 μL of the supernatant were transferred into a 5 mm standard NMR tube. Standard NMR tubes were purchased from Duran (DURAN Group GmbH, Wertheim, Germany). All NMR spectra were acquired on a Bruker Avance II 600 MHz spectrometer equipped with a 1H-BBI double resonance probe head (Bruker BioSpin GmbH, Rheinstetten, Germany). 1D NOESY experiments with presaturation for water suppression were recorded. A prescan delay of 4 s was used together with a mixing time of 10 ms. Pulse lengths were determined automatically by the Bruker AU program pulsecal. 64 k complex data points corresponding to a sweep width of 12,345.6 Hz were recorded. All spectra were treated identically using an exponential apodization function, introducing an additional linewidth of 0.3 Hz. Automated phasing, baseline correction, and referencing was done using the Bruker macro apk0.noe. Integration of spectra was done with AMIX 3.9.10 (Bruker BioSpin GmbH) using the multi integrate tool by summing up all points in specified chemical shift regions. Regions for each metabolite were determined individually for each solvent. The baseline was subtracted individually for each peak by subtracting a linear interpolation background defined by the baseline levels left and right of the signal. Peak positions were determined with TopSpin 3.2 (Bruker BioSpin GmbH). Peak assignment for all solvents was performed by adding pure substance to the samples and recording spectra before and after the addition.

4. Conclusions

In this article, we describe a systematic study testing the hypothesis if organic solvents might lead to a reduced variability of chemical shift positions of selected compounds. Unfortunately, the clear answer is that water seems to have the best NMR reproducibility of chemical shifts as compared to organic solvents. For nonpolar solvents, generally only a subset of substances is detected. MeOD, DMSO, and DMF as polar organic solvents are in principle applicable with urine in terms of solubility of metabolites. Variations in chemical shifts and signal integrals, however, are significantly higher than in D2O. The same result is found when various acid, base, or salt solutions are added to the samples. We therefore have to conclude that the exchange to organic solvents for urine samples is not advantageous in terms of chemical shift stability and general spectral variations.
  17 in total

Review 1.  Recent developments in sample preparation and data pre-treatment in metabonomics research.

Authors:  Ning Li; Yi peng Song; Huiru Tang; Yulan Wang
Journal:  Arch Biochem Biophys       Date:  2015-09-03       Impact factor: 4.013

2.  State-of-the art data normalization methods improve NMR-based metabolomic analysis.

Authors:  Stefanie M Kohl; Matthias S Klein; Jochen Hochrein; Peter J Oefner; Rainer Spang; Wolfram Gronwald
Journal:  Metabolomics       Date:  2011-08-12       Impact factor: 4.290

Review 3.  The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements.

Authors:  John C Lindon; Hector C Keun; Timothy Md Ebbels; Jake Mt Pearce; Elaine Holmes; Jeremy K Nicholson
Journal:  Pharmacogenomics       Date:  2005-10       Impact factor: 2.533

4.  Solubility of amino acids in pure solvent systems.

Authors:  T E Needham; A N Paruta; R J Gerraughty
Journal:  J Pharm Sci       Date:  1971-04       Impact factor: 3.534

5.  Effect of pH on 1H-NMR spectroscopy of mouse urine.

Authors:  Hideki Miyataka; Toshihiro Ozaki; Seiichiro Himeno
Journal:  Biol Pharm Bull       Date:  2007-04       Impact factor: 2.233

6.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts.

Authors:  Olaf Beckonert; Hector C Keun; Timothy M D Ebbels; Jacob Bundy; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  Integrative analysis of circadian transcriptome and metabolic network reveals the role of de novo purine synthesis in circadian control of cell cycle.

Authors:  Ying Li; Guang Li; Benjamin Görling; Burkhard Luy; Jiulin Du; Jun Yan
Journal:  PLoS Comput Biol       Date:  2015-02-25       Impact factor: 4.475

8.  The human urine metabolome.

Authors:  Souhaila Bouatra; Farid Aziat; Rupasri Mandal; An Chi Guo; Michael R Wilson; Craig Knox; Trent C Bjorndahl; Ramanarayan Krishnamurthy; Fozia Saleem; Philip Liu; Zerihun T Dame; Jenna Poelzer; Jessica Huynh; Faizath S Yallou; Nick Psychogios; Edison Dong; Ralf Bogumil; Cornelia Roehring; David S Wishart
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

9.  Influence of Freezing and Storage Procedure on Human Urine Samples in NMR-Based Metabolomics.

Authors:  Manuela J Rist; Claudia Muhle-Goll; Benjamin Görling; Achim Bub; Stefan Heissler; Bernhard Watzl; Burkhard Luy
Journal:  Metabolites       Date:  2013-04-09

10.  Reproducibility of NMR analysis of urine samples: impact of sample preparation, storage conditions, and animal health status.

Authors:  Christina Schreier; Werner Kremer; Fritz Huber; Sindy Neumann; Philipp Pagel; Kai Lienemann; Sabine Pestel
Journal:  Biomed Res Int       Date:  2013-06-23       Impact factor: 3.411

View more
  1 in total

1.  An Optimization of Liquid-Liquid Extraction of Urinary Volatile and Semi-Volatile Compounds and Its Application for Gas Chromatography-Mass Spectrometry and Proton Nuclear Magnetic Resonance Spectroscopy.

Authors:  Natalia Drabińska; Piotr Młynarz; Ben de Lacy Costello; Peter Jones; Karolina Mielko; Justyna Mielnik; Raj Persad; Norman Mark Ratcliffe
Journal:  Molecules       Date:  2020-08-11       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.